Partner Content Partner Content 3 things you should know about ADaM standards Digging deeper into the Analysis Data Model (ADaM)
Partner Content Partner Content Using SDTM, ADaM, and SEND for Regulatory Submissions Using SDTM, ADaM, and SEND for Regulatory Submissions
News Zymeworks cuts deal to buy Theravance for $929m in cash Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
